TY  - GEN
AU  - Zhang,Sai
AU  - Bastian,Nathaniel D
AU  - Griffin,Paul M
TI  - Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US
SN  - 1471-230X
PY  - 2016///0512
KW  - Antiviral Agents
KW  - economics
KW  - Benzimidazoles
KW  - Cost-Benefit Analysis
KW  - Drug Combinations
KW  - Drug Therapy, Combination
KW  - Female
KW  - Fluorenes
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Interferons
KW  - Macrocyclic Compounds
KW  - Male
KW  - Markov Chains
KW  - Middle Aged
KW  - Polyethylene Glycols
KW  - therapeutic use
KW  - Quality-Adjusted Life Years
KW  - Ribavirin
KW  - Ritonavir
KW  - Simeprevir
KW  - Sofosbuvir
KW  - Sulfonamides
KW  - Uracil
KW  - analogs & derivatives
KW  - Uridine Monophosphate
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/s12876-015-0320-4
ER  -